{"name":"Auspex Pharmaceuticals","permalink":"auspex-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/auspex-pharmaceuticals","homepage_url":"http://www.auspexpharma.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@auspexpharmaceuticals.com","phone_number":"(760) 599-1800","description":"","created_at":"Tue Oct 19 10:46:35 UTC 2010","updated_at":"Tue Oct 19 10:46:33 UTC 2010","overview":"<p>Auspex Pharmaceuticals, Inc., a deuteration company, engages in developing a pipeline of therapeutics that improves on existing drugs across various therapeutic areas. The company focuses on developing SD-254, a deuterium-substituted version of venlafaxine, for the treatment of depressive disorders. The company was founded in 2001 and is based in Vista, California.</p>","image":{"available_sizes":[[[150,68],"assets/images/resized/0010/6209/106209v1-max-150x150.png"],[[158,72],"assets/images/resized/0010/6209/106209v1-max-250x250.png"],[[158,72],"assets/images/resized/0010/6209/106209v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"COO","person":{"first_name":"Andreas","last_name":"Sommer","permalink":"andreas-sommer","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"R.","last_name":"Gary Gilmore","permalink":"r-gary-gilmore","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$12M","funding_rounds":[{"round_code":"c","source_url":"http://onbiovc.com/auspex-pharmaceuticals-inc-12m-series-c/","source_description":"Auspex Pharmaceuticals, Inc.: $12M Series C","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":13,"investments":[{"company":null,"financial_org":{"name":"Thomas, McNerney & Partners","permalink":"thomas-mcnerney-partners","image":{"available_sizes":[[[150,18],"assets/images/resized/0008/1733/81733v1-max-150x150.png"],[[250,30],"assets/images/resized/0008/1733/81733v1-max-250x250.png"],[[450,54],"assets/images/resized/0008/1733/81733v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"CMEA Ventures","permalink":"cmea-ventures","image":{"available_sizes":[[[150,136],"assets/images/resized/0002/3432/23432v1-max-150x150.jpg"],[[179,163],"assets/images/resized/0002/3432/23432v1-max-250x250.jpg"],[[179,163],"assets/images/resized/0002/3432/23432v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Sloan Biotech Funds","permalink":"sloan-biotech-funds","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"1261 Liberty Way","address2":"Suite C","zip_code":"92081","city":"Vista","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}